Environmental impact on the airways : from injury to repair /

Por Chrétien, Jacques, Dusser, Daniel
Publicado em 1996

Safety of tiotropium in patients with asthma

Por Dusser, Daniel, Ducharme, Francine M.
Publicado no Ther Adv Respir Dis (2019)

Tiotropium safety in ‘real‐world’ populations: Response to Schmiedl, et al. in the British Journal of Clinical Pharmacology

Por Wise, Robert, Anzueto, Antonio, Dahl, Ronald, Dusser, Daniel, Calverley, Peter
Publicado no Br J Clin Pharmacol (2016)

Poor Survival in Rheumatoid Arthritis Associated with Bronchiectasis: A Family-Based Cohort Study

Por Puéchal, Xavier, Génin, Emmanuelle, Bienvenu, Thierry, Le Jeunne, Claire, Dusser, Daniel J.
Publicado em 2014

A morphometric study of mucins and small airway plugging in cystic fibrosis

Por Burgel, Pierre‐Régis, Montani, David, Danel, Claire, Dusser*, Daniel J, Nadel*, Jay A
Publicado em 2007

Interleukin-10 Inhibits Elevated Chemokine Interleukin-8 and Regulated on Activation Normal T Cell Expressed and Secreted Production in Cystic Fibrosis Bronchial Epithelial Cells b...

Por Tabary, Olivier, Muselet, Céline, Escotte, Sandie, Antonicelli, Frank, Hubert, Dominique, Dusser, Daniel, Jacquot, Jacky
Publicado em 2003

The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes

Por Anzueto, Antonio, Wise, Robert, Calverley, Peter, Dusser, Daniel, Tang, Wenbo, Metzdorf, Norbert, Dahl, Ronald
Publicado no Respir Res (2015)

Genistein Inhibits Constitutive and Inducible NFκB Activation and Decreases IL-8 Production by Human Cystic Fibrosis Bronchial Gland Cells

Por Tabary, Olivier, Escotte, Sandie, Couetil, Jean Paul, Hubert, Dominique, Dusser, Daniel, Puchelle, Edith, Jacquot, Jacky
Publicado em 1999

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD

Por Calverley, Peter MA, Anzueto, Antonio R, Dusser, Daniel, Mueller, Achim, Metzdorf, Norbert, Wise, Robert A
Publicado no Int J Chron Obstruct Pulmon Dis (2018)

Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial

Por Dusser, Daniel, Wise, Robert A, Dahl, Ronald, Anzueto, Antonio, Carter, Kerstine, Fowler, Andy, Calverley, Peter M
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

Por Calverley, Peter MA, Tetzlaff, Kay, Dusser, Daniel, Wise, Robert A, Mueller, Achim, Metzdorf, Norbert, Anzueto, Antonio
Publicado no Int J Chron Obstruct Pulmon Dis (2017)

Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial

Por Wise, Robert, Calverley, Peter MA, Dahl, Ronald, Dusser, Daniel, Metzdorf, Norbert, Müller, Achim, Fowler, Andy, Anzueto, Antonio
Publicado no NPJ Prim Care Respir Med (2015)

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial

Por Dahl, Ronald, Calverley, Peter M A, Anzueto, Antonio, Metzdorf, Norbert, Fowler, Andy, Mueller, Achim, Wise, Robert, Dusser, Daniel
Publicado no BMJ Open (2015)

Rapid Emergence of Resistance to Linezolid and Mutator Phenotypes in Staphylococcus aureus Isolates from an Adult Cystic Fibrosis Patient

Por Tazi, Asmaa, Chapron, Jeanne, Touak, Gerald, Longo, Magalie, Hubert, Dominique, Collobert, Gislène, Dusser, Daniel, Poyart, Claire, Morand, Philippe C.
Publicado em 2013

Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat(®) in Asthma Using Standardized Sample-Contamination Avoidance

Por Beeh, Kai-Michael, Kirsten, Anne-Marie, Dusser, Daniel, Sharma, Ashish, Cornelissen, Piet, Sigmund, Ralf, Moroni-Zentgraf, Petra, Dahl, Ronald
Publicado no J Aerosol Med Pulm Drug Deliv (2016)

Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality

Por Burgel, Pierre-Régis, Paillasseur, Jean-Louis, Peene, Bernard, Dusser, Daniel, Roche, Nicolas, Coolen, Johan, Troosters, Thierry, Decramer, Marc, Janssens, Wim
Publicado em 2012

Tiotropium might improve survival in subjects with COPD at high risk of mortality

Por Burgel, Pierre-Régis, Paillasseur, Jean-Louis, Dusser, Daniel, Roche, Nicolas, Liu, Dacheng, Liu, Yufeng, Furtwaengler, Armin, Metzdorf, Norbert, Decramer, Marc
Publicado em 2014

The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale

Por Wise, Robert A, Anzueto, Antonio, Calverley, Peter, Dahl, Ronald, Dusser, Daniel, Pledger, Gordon, Koenen-Bergmann, Michael, Joseph, Elizabeth, Cotton, Daniel, Disse, Bernd
Publicado em 2013

Mediastinal Tuberculosis in an Adult Patient with Cystic Fibrosis

Por Morand, Philippe C., Burgel, Pierre-Régis, Carlotti, Agnès, Desmazes-Dufeu, Nadine, Farhi, David, Martin, Clémence, Kanaan, Reem, Mangialavori, Luigi, Palangié, Estelle, Dusser, Daniel, Poyart, Claire, Hubert, Dominique
Publicado em 2011

Determinants of mortality for adults with cystic fibrosis admitted in Intensive Care Unit: a multicenter study

Por Rabbat Antoine, Diehl Jean-Luc, Burgel Pierre-Régis, Choukroun Gérald, Jamal Dany, Texereau Joëlle, Loirat Philippe, Parrot Antoine, Duguet Alexandre, Coste Joël, Dusser Daniel, Hubert Dominique, Mira Jean-Paul
Publicado em 2006-01-01